Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Tiandi Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of traditional Chinese medicines (TCM) and chemical drugs. Based in Dafang County, Guizhou Province, the company operates large-scale production facilities for various dosage forms, including small-volume injections, capsules, and granules. Its product portfolio primarily focuses on respiratory health, cardiovascular support, and anti-infective treatments. In 2014, the company was acquired by Guizhou Bailing Group Pharmaceutical, a leading publicly traded pharmaceutical group in China, to strengthen its production capacity and market presence in the TCM sector. Guizhou Tiandi Pharmaceutical continues to serve as a key manufacturing and R&D hub within the Guizhou Bailing corporate structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Tiandi Pharmaceutical.